NCT01435174 - Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

End-stage Renal DiseaseCardiovascular Disease

Interventions

DRUG

Ranolazine

A single dose of two oral ranolazine extended release 500 mg tablets

PROCEDURE

Pharmacokinetic Blood and Dialysate Sampling

Blood samples collected to assess ranolazine plasma and dialysate concentrations.

PROCEDURE

QT Interval

Calculation of a QT interval will be performed throughout subject participation.

Trial Locations (1)

University of Michigan Hospital, Ann Arbor